{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:36:02Z","timestamp":1787070962394,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Carcinoma of the anal canal is relatively rare cancer with a low propensity for metastasis. A literature review identifies two cases with ischial fossa metastases from anal cancer. The authors present the case of a 62-year-old male with moderately differentiated squamous cell carcinoma of the anal canal who presented with isolated ischial fossa lymph node (LN) confirmed by fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography and pelvic magnetic resonance imaging. The patient was treated with concurrent chemoradiation. Ischial fossa LN was included in the high-dose radiation volume. Posttreatment imaging showed complete clinical response. This case highlights a rare metastatic site from anal cancer treated successfully with primary chemoradiation and shows an example of tailored treatment approach of oligometastatic disease from anal cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1158_19","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T06:11:37Z","timestamp":1606284697000},"page":"1202-1204","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Anal cancer with isolated ischial fossa lymph node metastases"],"prefix":"10.4103","volume":"18","author":[{"given":"Issa","family":"Mohamad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiz","family":"Abuhijlih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousa","family":"Alkaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Al-Ibraheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Khatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawzi","family":"Abuhijla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-57-20241021","first-page":"756591","article-title":"Metastatic squamous cell carcinoma of the anus: Time for a shift in the treatment paradigm?","volume":"2012","author":"Dewdney","year":"2012","journal-title":"ISRN Oncol"},{"key":"R2-57-20241021","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1148\/radiographics.18.1.9460109","article-title":"The normal and pathologic ischiorectal fossa at CT and MR imaging","volume":"18","author":"Llauger","year":"1998","journal-title":"Radiographics"},{"key":"R3-57-20241021","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","article-title":"Elective clinical target volumes for conformal therapy in anorectal cancer: A radiation therapy oncology group consensus panel contouring atlas","volume":"74","author":"Myerson","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R4-57-20241021","doi-asserted-by":"crossref","first-page":"314","DOI":"10.5152\/dir.2016.15478","article-title":"Use of MRI to identify enlarged inferior gluteal and ischioanal lymph nodes and associated findings related to the primary disease","volume":"22","author":"Uzun","year":"2016","journal-title":"Diagn Interv Radiol"},{"key":"R5-57-20241021","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.bjc.6604897","article-title":"The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer","volume":"100","author":"Winton","year":"2009","journal-title":"Br J Cancer"},{"key":"R6-57-20241021","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13014-017-0883-z","article-title":"Target volume delineation of anal cancer based on magnetic resonance imaging or positron emission tomography","volume":"12","author":"Rusten","year":"2017","journal-title":"Radiat Oncol"},{"key":"R7-57-20241021","first-page":"198","article-title":"Technical aspects of radiation therapy for anal cancer","volume":"5","author":"Scher","year":"2014","journal-title":"J Gastrointest Oncol"},{"key":"R8-57-20241021","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.21037\/jgo.2015.11.02","article-title":"A combined modality therapeutic approach to metastatic anal squamous cell carcinoma with systemic chemotherapy and local therapy to sites of disease: Case report and review of literature","volume":"7","author":"Gnanajothy","year":"2016","journal-title":"J Gastrointest Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1158_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:39:40Z","timestamp":1787067580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1158_19"}},"subtitle":["A rare entity in the oligometastatic dilemma"],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1158_19","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}